Literature DB >> 15033250

Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population.

Anna-Lena Eriksson1, Stanko Skrtic, Anders Niklason, Lillemor Mattsson Hultén, Olov Wiklund, Thomas Hedner, Claes Ohlsson.   

Abstract

AIM: Estrogens regulate several biological processes involved in the pathogenesis of myocardial infarction. Catechol-O-methyltransferase (COMT) is a key enzyme in the degradation of estrogens. There is a functional polymorphism in the COMT gene (Val158Met), affecting the activity of the enzyme. We investigated if the low activity genotype of COMT is associated with an altered risk of myocardial infarction. METHODS AND
RESULTS: In a prospectively followed hypertensive cohort we identified 174 patients who suffered a myocardial infarction during the study and compared them to 348 controls from the same cohort. The COMT polymorphism and serum levels of sex hormones were analysed. Patients homozygous for the low activity COMT genotype had a decreased risk of myocardial infarction compared to those with the high activity genotype, odds ratio 0.65 (95% CI 0.44-0.97, p=0.033 ). The protective effect of the low activity genotype was most evident among older patients (> 58 years of age), odds ratio 0.43 (95% CI 0.23-0.79, p=0.006 ). Serum levels of estradiol were increased ( p=0.006 ) in males with the low activity genotype.
CONCLUSIONS: Our findings suggest that the low activity COMT genotype is protective against myocardial infarction. One may speculate that the altered estrogen status could be involved in this effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033250     DOI: 10.1016/j.ehj.2003.12.026

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Catechol-O-methyltransferase promoter hypomethylation is associated with the risk of coronary heart disease.

Authors:  Jinyan Zhong; Xiaoying Chen; Nan Wu; Caijie Shen; Hanbin Cui; Weiping Du; Zhaoxia Zhang; Mingjun Feng; Junsong Liu; Shaoyi Lin; Lulu Zhang; Jian Wang; Xiaomin Chen; Shiwei Duan
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

2.  Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt.

Authors:  Beverly J Wolpert; Sania Amr; Doa'a A Saleh; Sameera Ezzat; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Nabiel N Mikhail; Min Zhan; Yun-Ling Zheng; Katherine Squibb; Mohamed A Abdel-Aziz; Mohamed S Zaghloul; Hussein Khaled; Christopher A Loffredo
Journal:  Urol Oncol       Date:  2011-03-11       Impact factor: 3.498

3.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

Review 4.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

5.  A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2).

Authors:  L T Roten; M H Fenstad; S Forsmo; M P Johnson; E K Moses; R Austgulen; F Skorpen
Journal:  Mol Hum Reprod       Date:  2011-02-25       Impact factor: 4.025

6.  Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.

Authors:  Sari Voutilainen; Tomi-Pekka Tuomainen; Maarit Korhonen; Jaakko Mursu; Jyrki K Virtanen; Pertti Happonen; Georg Alfthan; Iris Erlund; Kari E North; M J Mosher; Jussi Kauhanen; Jari Tiihonen; George A Kaplan; Jukka T Salonen
Journal:  PLoS One       Date:  2007-01-31       Impact factor: 3.240

7.  The impact of the catechol-O-methyltransferase Val158Met polymorphism on survival in the general population--the HUNT study.

Authors:  Knut Hagen; Lars J Stovner; Frank Skorpen; Elin Pettersen; John-Anker Zwart
Journal:  BMC Med Genet       Date:  2007-06-19       Impact factor: 2.103

8.  Association of Catechol-O-methyltransferase (COMT Val158Met) with future risk of cardiovascular disease in depressed individuals - a Swedish population-based cohort study.

Authors:  Aysha Almas; Yvonne Forsell; Vincent Millischer; Jette Möller; Catharina Lavebratt
Journal:  BMC Med Genet       Date:  2018-07-25       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.